EORTC GUCG Group

FEASIBILITY FORM: EORTC trial "1407"


TIGER: A randomised phase III trial comparing conventional-Dose chemotherapy using paclitaxel, ifosfamide, and cisplatin (TIP) with high dose chemotherapy using mobilizing paclitaxel followed by High-dose carboplatin and etoposide (TI-CE) as first salvage treatment in relapsed or refractory germ cell tumours"


Projected start: Q1. 2015

 

THIS FEASIBILITY IS CLOSED